BRITTANY LAFREE: Open Payments
NPI 1710213624 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,738 in 218 payments from 21 companies in 2025. Trend: 2023 $2,389 · 2024 $2,504 · 2025 $2,738
Food & beverage: $2,731Education: $7
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 33 | $392 |
| ABBVIE INC. | 28 | $369 |
| UCB, Inc. | 24 | $316 |
| Novartis Pharmaceuticals Corporation | 24 | $240 |
| Galderma Laboratories, L.P. | 21 | $207 |
| Regeneron Healthcare Solutions, Inc. | 15 | $207 |
| Amgen Inc. | 15 | $196 |
| Janssen Biotech, Inc. | 16 | $180 |
| LEO Pharma Inc. | 17 | $168 |
| GENZYME CORPORATION | 5 | $96 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, NEMLUVIO, Otezla, Winlevi, ILUMYA, TREMFYA.
Industry payments across IN — which companies pay providers there.
